Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database

BACKGROUND: Prostacyclins play an important role in the management of pulmonary arterial hypertension (PAH). Intravenous prostacyclin was the first disease-specific treatment for patients with PAH. Subcutaneous and nonparenteral (oral or inhaled) formulations have subsequently become available. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Charles D., Pruett, Janis A., Lickert, Cassandra A., Berger, Ariel, Murphy, Brian, Drake, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397685/
https://www.ncbi.nlm.nih.gov/pubmed/29406840
http://dx.doi.org/10.18553/jmcp.2017.17228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397685/
https://www.ncbi.nlm.nih.gov/pubmed/29406840
http://dx.doi.org/10.18553/jmcp.2017.17228

Ejemplares similares